Data / Form D filings / TRIDENT PHARMACEUTICALS INC
TRIDENT PHARMACEUTICALS INC: Form D filing
TRIDENT PHARMACEUTICALS INC, a technology company in Boston, MA, filed a Form D with the SEC in 2014. The latest, on May 21, 2014, reports $275,187 sold of a $825,561 offering to 4 investors.
Find out what TRIDENT PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 184 HIGH STREET, Boston, MA, 02110
- Phone
- (857) 366-8459
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1359349
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Other Technology: 8,166 rows, $161.66, or the new rows each week for $19.25 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 21, 2014 | New notice | $825,561 | $275,187 | $550,374 | 4 | May 6, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Murray | Director | |
| Robin Brown | Executive Officer | |
| Charlie Cohen | Executive Officer, Director | |
| Jason Fisherman | Director | |
| Richard Lim | Director | |
| Thomas Needham | Executive Officer, Director |
Other technology companies in Massachusetts that filed recently
- Flip Flow HQ Inc $71,000 · Nov 9, 2026
- Accelerate, LLC $25,000 · Nov 9, 2026
- Newton Research, Inc. $17.9 million · Nov 9, 2026
- Multikor.ai, Inc. $137,500 · Nov 6, 2026
- Infinite Cooling Inc. $6.9 million · Nov 6, 2026
- Sanaren, Inc. $100,000 · Nov 5, 2026
- Trinity AI Boston, Inc. $6 million · Nov 5, 2026
- VentureCare Partners Inc. $1.3 million · Nov 5, 2026
- Tremont AI, Inc. $2 million · Nov 4, 2026
- MitoAI Inc. $5.4 million · Nov 4, 2026
- Lithios Inc. $5.1 million · Nov 4, 2026
- Rgenta Therapeutics, Inc. $41.9 million · Nov 3, 2026
- Betvisors, Inc. $150,000 · Oct 30, 2026
- RESOLV TECHNOLOGY, INC. $7.2 million · Oct 30, 2026
- Cala Systems, Inc. $2.6 million · Oct 27, 2026
Every Form D from the week of May 19, 2014 · All recent filings in Massachusetts · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what TRIDENT PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.